<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="GEO" alias="GSE137366" accession="SRP221510">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP221510</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA565248</EXTERNAL_ID>
      <EXTERNAL_ID namespace="GEO">GSE137366</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Gene expression after treatment with Nutlin 3a (Nut) and Selinexor (Sel) in Neuroblastoma Cells</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Transcriptome Analysis"/>
      <STUDY_ABSTRACT>Gene expression after treatment with Nutlin 3a (Nut) and Selinexor (Sel) in Neuroblastoma Cells RNA from NBAT1 knockdown and its respective control (Csh) SH-SY5Y cells after nutlin-3a (10 uM) or DMSO treatement were isolated and sequenced using  BGI DNBseq.  IMR32 cells were treated with either DMSO, Nut, Sel and with both Nul and Sel and RNA was isolated following treatemnet We observed that knowndown of the NBAT1 lncRNA in NB cells leads to perturbation of the P53 mediated gene expression. Combination treatment with with Nul and Sel in IMR32 cells leads to higher P53 mediated gene expression. Overall design: Nutlin 3a treatment after known down of lncRNA NBAT1 in SHSY-5Y cells. IMR32 cells were treated with either Nut or Sel or combination of both the drugs.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>GSE137366</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
